Acyclovir Injection, Solution
Product Images NDC 70436-030

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 70436-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Acyclovir-chemical-structure (Image 01)

Acyclovir-chemical-structure (Image 01)
Chemical structure of acyclovir sodium, showing the molecular arrangement including a purine derivative with hydroxyl and amine groups, and a sodium ion indicated.*
FDA Label Image

70436-030-82 (Image 02)

70436-030-82 (Image 02)
A label for Acyclovir Injection, USP with strength 500 mg per 10 mL (50 mg per mL). It is a sterile, nonpyrogenic intravenous solution for single-dose vial use. The label includes instructions to dilute to 7 mg/mL or lower prior to infusion and storage guidance between 20° to 25°C. Manufactured by Slate Run Pharmaceuticals, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.